SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934




Date of Report (Date of earliest event reported):  November 4, 2004



                        DOBI MEDICAL INTERNATIONAL, INC.
                        --------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                         0-32523                 98-0222710
(State or other jurisdiction          (Commission             (I.R.S. Employer
      of incorporation)               File Number)           Identification No.)

    1200 MacArthur Blvd.
     Mahwah, New Jersey                                             07430
    (Address of principal                                        (Zip Code)
     executive offices)


Registrant's telephone number, including area code:  (201) 760-6464






                           CURRENT REPORT ON FORM 8-K


                        DOBI MEDICAL INTERNATIONAL, INC.


                                November 4, 2004


Item 2.02. Results of Operations and Financial Condition.

         On November 4, 2004, DOBI Medical International, Inc. issued a press
release announcing its financial results for the third quarter of fiscal 2004. A
copy of the press release is included as Exhibit 99.1 to this report and is
incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits.

         99.1 Press release issued by DOBI Medical International, Inc. on
November 4, 2004.





                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                             DOBI MEDICAL INTERNATIONAL, INC.


Dated:  November 5, 2004                     By: /s/Phillip C. Thomas
                                                 -------------------------------
                                                   Phillip C. Thomas
                                                   Chief Executive Officer